Target intelligence / Profile preview

Glucosamine-6-phosphate riboswitch ribozyme (glmS ribozyme)

Target
glmS ribozyme
Molecular classification
Ribozyme, Riboswitch, Catalytic RNA, Regulatory RNA
01

Overview

The **glucosamine-6-phosphate riboswitch ribozyme** (glmS ribozyme) is a catalytic RNA motif found in the 5′ untranslated region (UTR) of the mRNA encoding **glucosamine-6-phosphate synthetase** (GlmS), predominantly in Gram-positive bacteria[1][2][6][7]. This ribozyme uniquely combines characteristics of both a **riboswitch** (an RNA element that senses metabolite concentrations and alters gene expression) and a **ribozyme** (an RNA molecule with catalytic activity)[1][6]. It acts as a metabolite-activated, self-cleaving RNA, using the product of its own regulated gene (**glucosamine-6-phosphate; GlcN6P**) as a cofactor to trigger mRNA cleavage[1][2][3][5][7][8]. The result is negative feedback: when cellular GlcN6P is abundant, glmS ribozyme cleaves its host mRNA, reducing GlmS enzyme production and thus GlcN6P synthesis further[1][3][6]. Structurally, the ribozyme forms a compact tertiary structure with multiple pseudoknots and specifically binds GlcN6P, which acts in acid-base catalysis during RNA cleavage[1][3][5]. The ribozyme pre-folds into its active state before ligand binding, and GlcN6P does not induce gross conformational change, acting more as a true coenzyme than a classical allosteric ligand[1][3][5]. The glmS ribozyme is a well-established model for co-transcriptional gene regulation and is a potential target for novel antibiotics aimed at disrupting bacterial cell wall synthesis by interfering with mRNA stability of essential genes[4][7][6]. No clinically approved drugs directly target the glmS ribozyme, but inhibitors could, in theory, disrupt its regulatory feedback loop and impair bacterial viability, making it a candidate for antibacterial drug development[4][7].

Other names
glmS ribozymeglmS riboswitchGlmS glucosamine-6-phosphate activated ribozyme
02

Mechanism of action

Ligand-activated self-cleavage: The small molecule metabolite **glucosamine-6-phosphate** (GlcN6P) acts as a cofactor to trigger site-specific RNA self-cleavage, leading to mRNA degradation and decreased protein synthesis[1][2][3][4][7][8].

03

Biological functions

Gene expression regulationmRNA self-cleavageMetabolite sensingNegative feedback control of enzyme biosynthesis
04

Disease associations

Infection (as a potential antibacterial target)
05

Safety considerations

Lack of selectivity may affect bacterial mRNA stability globally if not specifically targetedNo established drugs, so clinical safety issues are not established

Beyond the preview

Go deeper on Glucosamine-6-phosphate riboswitch ribozyme (glmS ribozyme).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glucosamine-6-phosphate riboswitch ribozyme (glmS ribozyme).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call